| 发明名称 | Compositions and methods for treatment during non-acute periods following CNS neurological injury | ||
| 摘要 | This invention relates to treatment of neuroinjury in a post-acute window or in a chronic period following neuroinjury. | ||
| 申请公布号 | US9498515(B2) | 申请公布日期 | 2016.11.22 |
| 申请号 | US200913059206 | 申请日期 | 2009.08.17 |
| 申请人 | Acorda Therapeutics, Inc. | 发明人 | Caggiano Anthony;Iaci Jennifer |
| 分类号 | A61K38/00;A61K38/16;A61K38/18 | 主分类号 | A61K38/00 |
| 代理机构 | Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. | 代理人 | Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. ;Bauer, Esq. John A.;Mitra Linyu L. |
| 主权项 | 1. A method for treating a neuroinjury resulting from a stroke in a mammal comprising administering a polypeptide comprising an epidermal growth factor like (EGF-like) domain of Glial Growth Factor 2 (GGF2), wherein the EGF-like domain comprises the amino acid sequence of SEQ ID NO: 18, to the mammal following said neuroinjury in said mammal, wherein the administering step is initiated at least one day after said neuroinjury. | ||
| 地址 | Ardsley NY US | ||